Charlottesville, VA – December 7, 2015 – HemoSonics, a medical device company developing a point-of-care diagnostic platform to guide the management of critical bleeding, today announced that it has opened a new facility in Durham, NC.
“The expertise in hemostasis in the Research Triangle is unparalleled, and we are excited to have a new facility that will leverage the wealth of talent in the region. This new facility will support the final stage of development and clinical testing of our Quantra™ platform,” said Tim Fischer, CEO of HemoSonics. “The university ecosystem provides ample sites for clinical testing and we have built out a strong team to fuel our future growth.”
The Durham Facility currently has 11 employees. The facility will focus on software development, system engineering, reagent development, and clinical affairs.